HeartFlow adds Tim Barabe to its Board of Directors

– USA, CA –  HeartFlow Holding, Inc., the leader in revolutionizing precision heart care, today announced the appointment of Tim Barabe to its Board of Directors.

“We are honored to have an accomplished leader like Tim join the HeartFlow Board. Tim’s background and expertise in financial strategy, operations, and stewardship will add important perspectives to the Board as we enter our next phase of growth,” said Board Chairman, Bill Weldon.

About Timothy Barabe

Tim Barabe brings more than 30 years of experience in the life sciences industry, across a broad range of financial and strategic roles. Most recently, Mr. Barabe served as CFO and executive vice president at Affymetrix Inc., where he led the company’s financial functions as well as the treasury, investor relations, and information technology departments. Previously, he served as senior vice president and CFO at Human Genome Sciences, where he worked with the leadership team to drive the financial strategy and operations of the company. For more than 20 years, he held senior international executive roles in finance, general management, and strategic planning at Novartis AG. His roles included CFO of the Sandoz Generics Business Unit, president of the CIBA Vision Corporation Specialty Lens Business Franchise, and group VP and CFO of CIBA Vision Corporation.

Mr. Barabe currently serves as a Board member and Audit Committee Chair of Selecta Biosciences, Inc., and on the board of Vigilant Biosciences, a privately-held medical device company. He previously served on the Boards of Veeva Systems, Inc., ArQule, Opexa Therapeutics, Autonomous Technologies, and BioCure, Inc. As an active philanthropist, Tim is involved in a range of charitable causes and served on the board of Project Open Hand, a San Francisco-based non-profit organization focused on serving nutritious meals to vulnerable populations from 2014 to 2020.

“I am thrilled to join the Board of Directors for HeartFlow as the company is at a key inflection point in its growth trajectory,” said Tim Barabe. “I look forward to leveraging my experience and working with the team to make HeartFlow’s game-changing technology broadly available to more patients worldwide.”

Mr. Barabe has a Bachelor of Business Administration in finance from the University of Massachusetts (Amherst) and an MBA from the University of Chicago.

About HeartFlow

HeartFlow is the leader in revolutionizing precision heart care, uniquely combining human ingenuity with advanced technology. HeartFlow’s non-invasive HeartFlow FFRct Analysis leverages artificial intelligence to create a personalized three-dimensional model of the heart. Clinicians can use this model to evaluate the impact a blockage has on blood flow and determine the best treatment for patients. HeartFlow’s technology is reflective of our Silicon Valley roots and incorporates over two decades of scientific evidence with the latest advances in artificial intelligence. The HeartFlow FFRct Analysis is commercially available in the United States, UK, Canada, Europe, and Japan.

For more information: https://www.heartflow.com/

- DisclaimerNews, data, and statements included in this release are intended exclusively for general information purposes. Talent4Boards does not guarantee that news is accurate or about the correct person and accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the accuracy of the information. Nothing in this release should be considered for decisions about referred securities. Products and brand names may be trademarks or registered trademarks of their respective owners.

Talent4Boards Team